A. Kaya Et Al. , "Paclitaxel plus doxorubicin chemotherapy as second-line therapy in patients with advanced urothelial carcinoma pretreated with platinum plus gemcitabine chemotherapy.," Onkologie , vol.35, pp.576-80, 2012
Kaya, A. Et Al. 2012. Paclitaxel plus doxorubicin chemotherapy as second-line therapy in patients with advanced urothelial carcinoma pretreated with platinum plus gemcitabine chemotherapy.. Onkologie , vol.35 , 576-80.
Kaya, A., Coskun, U., Ozkan, M., Sevinc, A., Yilmaz, A., Gumus, M., ... Unal, O.(2012). Paclitaxel plus doxorubicin chemotherapy as second-line therapy in patients with advanced urothelial carcinoma pretreated with platinum plus gemcitabine chemotherapy.. Onkologie , vol.35, 576-80.
Kaya, AO Et Al. "Paclitaxel plus doxorubicin chemotherapy as second-line therapy in patients with advanced urothelial carcinoma pretreated with platinum plus gemcitabine chemotherapy.," Onkologie , vol.35, 576-80, 2012
Kaya, AO Et Al. "Paclitaxel plus doxorubicin chemotherapy as second-line therapy in patients with advanced urothelial carcinoma pretreated with platinum plus gemcitabine chemotherapy.." Onkologie , vol.35, pp.576-80, 2012
Kaya, A. Et Al. (2012) . "Paclitaxel plus doxorubicin chemotherapy as second-line therapy in patients with advanced urothelial carcinoma pretreated with platinum plus gemcitabine chemotherapy.." Onkologie , vol.35, pp.576-80.
@article{article, author={AO Kaya Et Al. }, title={Paclitaxel plus doxorubicin chemotherapy as second-line therapy in patients with advanced urothelial carcinoma pretreated with platinum plus gemcitabine chemotherapy.}, journal={Onkologie}, year=2012, pages={576-80} }